Abbott Laboratories’ purchase of Solvay SA’s pharmaceutical unit, for about 4.8 billion euros (US$7.1 billion), will give it full control of the TriCor cholesterol drug and a bigger presence in emerging markets.
Abbott will pay 4.5 billion euros in cash, with as much as 300 million euros in contingent payments between 2011 and 2013. The milestone payments relate to whether products perform well. The agreement also includes the assumption about 400 million euros of pension liabilities, Solvay said in a statement yesterday.
The purchase will lower Abbott’s dependence on the arthritis drug Humira, said Larry Biegelsen, a Wells Fargo Securities LLC analyst, in a report on Friday. The company’s biggest product with US$4.5 billion in revenue last year, Humira risks losing sales as consumers cut spending. Solvay, which also makes chemicals and plastics, wasn’t big enough to compete in pharmaceuticals, chief executive officer Christian Jourquin said.
“If the deal is completed, it would reduce Humira’s share of Abbott’s total sales to 15 percent from the current level of 18 percent,” Biegelsen wrote.
Based in New York, he recommends holding Abbott shares.
The deal also suggests Abbott is comfortable with the landscape for TriCor and TriLipix, cholesterol drugs it co-promotes with Solvay. Both use the active ingredient fenofibrate, and account for about 20 percent of Brussels-based Solvay’s pharmaceutical sales, Biegelsen wrote.
TriCor faces generic competition by 2011 and Abbott is seeking regulatory approval to market TriLipix in combination with AstraZeneca Plc’s Crestor. TriCor generated US$1.34 billion in revenue last year for Abbott, of Abbott Park, Illinois, and 511 million euros for Brussels-based Solvay.
Solvay rose 2.15 euros, or 2.9 percent, to 76.88 euros at 9:10am in Brussels, giving the company a market value of 6.5 billion euros. Abbott rose US$0.39 to US$47.33 in New York Stock Exchange composite trading on Friday.
Buying Solvay’s drug business represents a change of course for chief executive officer Miles White, who has been acquiring medical devices and eye products to reduce Abbott’s reliance on medicines as the company battles generic competition to its anti-seizure treatment Depakote.
Solvay’s pharmaceutical unit brought in 2.7 billion euros in revenue last year, 24 percent of the company’s total sales. It focuses on therapeutic areas such as cardiometabolics, which includes its best-seller, TriCor, and neuroscience, including the Duodopa treatment for Parkinson’s disease.
TriCor is used to reduce triglycerides and adjust cholesterol levels. Solvay’s other top-selling products are Androgel, a testosterone gel, and Creon, a pancreatic enzyme to treat cystic fibrosis.
The purchase may add to Abbott’s earnings immediately, UBS analyst Bruce Nudell wrote in a research note on Friday. He cited a 5 percent to 7 percent increase to cash earnings-per-share in the first three years.
ROLLER-COASTER RIDE: More than five earthquakes ranging from magnitude 4.4 to 5.5 on the Richter scale shook eastern Taiwan in rapid succession yesterday afternoon Back-to-back weather fronts are forecast to hit Taiwan this week, resulting in rain across the nation in the coming days, the Central Weather Administration said yesterday, as it also warned residents in mountainous regions to be wary of landslides and rockfalls. As the first front approached, sporadic rainfall began in central and northern parts of Taiwan yesterday, the agency said, adding that rain is forecast to intensify in those regions today, while brief showers would also affect other parts of the nation. A second weather system is forecast to arrive on Thursday, bringing additional rain to the whole nation until Sunday, it
LANDSLIDES POSSIBLE: The agency advised the public to avoid visiting mountainous regions due to more expected aftershocks and rainfall from a series of weather fronts A series of earthquakes over the past few days were likely aftershocks of the April 3 earthquake in Hualien County, with further aftershocks to be expected for up to a year, the Central Weather Administration (CWA) said yesterday. Based on the nation’s experience after the quake on Sept. 21, 1999, more aftershocks are possible over the next six months to a year, the agency said. A total of 103 earthquakes of magnitude 4 on the local magnitude scale or higher hit Hualien County from 5:08pm on Monday to 10:27am yesterday, with 27 of them exceeding magnitude 5. They included two, of magnitude
CONDITIONAL: The PRC imposes secret requirements that the funding it provides cannot be spent in states with diplomatic relations with Taiwan, Emma Reilly said China has been bribing UN officials to obtain “special benefits” and to block funding from countries that have diplomatic ties with Taiwan, a former UN employee told the British House of Commons on Tuesday. At a House of Commons Foreign Affairs Committee hearing into “international relations within the multilateral system,” former Office of the UN High Commissioner for Human Rights (OHCHR) employee Emma Reilly said in a written statement that “Beijing paid bribes to the two successive Presidents of the [UN] General Assembly” during the two-year negotiation of the Sustainable Development Goals. Another way China exercises influence within the UN Secretariat is
Taiwan’s first drag queen to compete on the internationally acclaimed RuPaul’s Drag Race, Nymphia Wind (妮妃雅), was on Friday crowned the “Next Drag Superstar.” Dressed in a sparkling banana dress, Nymphia Wind swept onto the stage for the final, and stole the show. “Taiwan this is for you,” she said right after show host RuPaul announced her as the winner. “To those who feel like they don’t belong, just remember to live fearlessly and to live their truth,” she said on stage. One of the frontrunners for the past 15 episodes, the 28-year-old breezed through to the final after weeks of showcasing her unique